27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

Lonza Group Ltd.<br />

Muenchensteinerstrasse 38<br />

Basel CH-4002, Switzerland<br />

Phone: +41 61-316-8111; Fax: +41 61-316-9111<br />

Web: www.lonza.com<br />

E-mail: contact@lonza.com<br />

KEY PERSONNEL: Rolf Soiron, Ph.D.; Chairman<br />

Stefan Borgas; CEO<br />

Toralf Haag, Ph.D.; CFO<br />

Lukas Utiger, Ph.D.; Head, Organic Fine & Performance Chemicals<br />

Stephan Kutzer, Ph.D.; Head, Biopharmaceuticals<br />

Rosario Valido; Head, Polymer Intermediates<br />

EMPLOYEES: 6,400 employees<br />

HISTORY: Founded in 1897<br />

Acquired biologics contract manufacturing business of UCB (1/06)<br />

Member--Biotechnology Industry Organization<br />

FACILITIES: Headquarters in Basel, Switzerland<br />

R&D facilities in Visp, Switzerland; Slough, U.K.; Portsmouth, N.H.; and<br />

Guangzhou, China<br />

Manufacturing facilities in Visp, Switzerland; Kourim, Czech Republic;<br />

Slough, U.K.; Portsmouth, N.H.; and Conshohocken, Pa.<br />

STOCK-FINANCIAL HISTORY: Financial data for the Lonza Group:<br />

Sales CHF2.521b (YE 05) compared to CHF2.182b (YE 04)<br />

Net income CHF188M (YE 05) compared to CHF138M (YE 04)<br />

Earnings per share CHF3.97/share (YE 05) compared to CHF2.91/share<br />

(YE 04)<br />

Total assets CHF4.331b (YE 05) compared to CHF3.341b (YE 04)<br />

SUBSIDIARIES/DIVISIONS: Exclusive Synthesis & Biopharmaceuticals<br />

Organic Fine & Performance Chemicals<br />

Polymer Intermediates<br />

BUSINESS STRATEGY: Lonza develops products and processes for fine chemicals and active<br />

pharmaceutical ingredients in R&D centres and manufacturing plants in the<br />

U.S., Europe and Asia<br />

Lonza offers custom manufacturing services in the fields of monoclonal<br />

antibodies, therapeutic proteins, biotransformations and fermentation<br />

RESEARCH & DEVELOPMENT: Organic intermediates and APIs<br />

Biotransformation projects<br />

Fermentation processes (microbial and mammalian technologies)<br />

PRODUCTS ON MARKET: Lonza offers a wide range of organic intermediates and active substances<br />

Maine Biotechnology Services Inc.<br />

1037R Forest Avenue<br />

Portland ME 04103, US<br />

Phone: (207) 797-5454; Fax: (207) 797-5595<br />

Toll-free phone: (800) 925-9476<br />

Web: www.mainebiotechnology.com<br />

E-mail: info@mainebiotechnology.com<br />

KEY PERSONNEL: Joseph P. Chandler, Ph.D.; President<br />

Carrie Cloutier; Sales Director, Custom Services<br />

Michael Sullivans; Production Manager<br />

EMPLOYEES: 35 employees, 1 Ph.D.<br />

Copyright ©2006 AHC Media ® 227

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!